JOHN A LUST, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 28758
Category
Osteopathic Medicine
Type
Hematology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about JOHN A LUST at bizstanding.comJohn Lust MD,PHD
200 1 St SW, Rochester, MN 55905
Industry:
Internist
Phone:
(800) 660-4582 (Phone)
Description:
There are 82 doctors at this site. Surgery is not performed at this site.
John Anthony Lust
Mayo Clinic - John A Lust MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Physicians & Surgeons
Phone:
(507) 284-2017 (Phone)
Professional information
Dr. John A Lust, Rochester MN - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Hematology, 2001, Internal Medicine, 1986, Medical Oncology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
Education:
Medical School
Boston University School Of Medicine
Graduated: 1983
Mayo Grad School Med
Graduated: 1984
Graduated: 1986
Boston University School Of Medicine
Graduated: 1983
Mayo Grad School Med
Graduated: 1984
Graduated: 1986
John A Lust, Rochester MN
Specialties:
Internist
Address:
200 1St St Sw, Rochester, MN 55905
Education:
Boston University, School of Medicine - Doctor of Medicine*
The Mayo Clinic - Fellowship - Hematology and Oncology (Internal Medicine)*
The Mayo Clinic - Residency - Internal Medicine*
The Mayo Clinic - Fellowship - Hematology and Oncology (Internal Medicine)*
The Mayo Clinic - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)*
John Anthony Lust, Rochester MN
Specialties:
Internal Medicine, Hematology, Pathology
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
Boston University(1983)
John Lust
Location:
Rochester, Minnesota Area
Industry:
Medical Practice
Il1-Β: A New Target For Myeloma Therapy
US Patent:
7820167, Oct 26, 2010
Filed:
Jan 26, 2005
Appl. No.:
11/043209
Inventors:
Kathleen A. Donovan - Rochester MN, US
John A. Lust - Rochester MN, US
John A. Lust - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 39/395, A61K 38/16, A61K 38/20
US Classification:
4241451, 424 852, 4241341, 514 2
Abstract:
Diagnostic methods for the detection of multiple myeloma (MM) and the identification of high-risk patients with multiple myeloma-related plasma proliferative disorders, such as MGUS or SMM, likely to progress to active MM are described. The diagnosis is based on the determination of concentrations of bioactive IL-1β produced by the bone marrow plasma cells of these patients. Also described are therapeutic methods for the treatment of MM and for the chemoprevention of the progression from disorders such as MGUS and SMM to active MM, involving the administration of inhibitors of IL-1β.
Use Of Genetically Engineered Antibodies To Treat Multiple Myeloma
US Patent:
2001003, Oct 18, 2001
Filed:
Dec 5, 2000
Appl. No.:
09/730374
Inventors:
John Lust - Rochester MN, US
Kathleen Donovan - Rochester MN, US
Kathleen Donovan - Rochester MN, US
International Classification:
A61K039/395, C07H021/04, C12P021/04, C07K016/30
US Classification:
424/178100, 536/023500, 435/069700, 530/391100
Abstract:
A fusion polypeptide comprising an antibody or a fragment thereof is provided. The fusion polypeptide is useful in a therapeutic composition to treat multiple myeloma.
Il1-Beta: A New Target For Myeloma Therapy
US Patent:
2002017, Nov 28, 2002
Filed:
Mar 29, 2001
Appl. No.:
09/821719
Inventors:
Kathleen Donovan - Rochester MN, US
John Lust - Rochester MN, US
John Lust - Rochester MN, US
International Classification:
A61K039/395, G01N033/574
US Classification:
424/145100, 435/007230
Abstract:
Diagnostic methods for the detection of multiple myeloma (MM) and the identification of high-risk patients with multiple myeloma-related plasma proliferative disorders, such as MGUS or SMM, likely to progress to active MM are described. The diagnosis is based on the determination of concentrations of bioactive IL-1 produced by the bone marrow plasma cells of these patients. Also described are therapeutic methods for the treatment of MM and for the chemoprevention of the progression from disorders such as MGUS and SMM to active MM, involving the administration of inhibitors of IL-1.
Use Of Genetically Engineered Antibodies To Treat Multiple Myeloma
US Patent:
2004014, Jul 22, 2004
Filed:
Nov 7, 2003
Appl. No.:
10/704206
Inventors:
John Lust - Rochester MN, US
Kathleen Donovan - Rochester MN, US
Kathleen Donovan - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research
International Classification:
A61K048/00, A61K039/395
US Classification:
424/178100, 514/044000
Abstract:
A fusion polypeptide comprising an antibody or a fragment thereof is provided. The fusion polypeptide is useful in a therapeutic composition to treat multiple myeloma.